Volume : 09, Issue : 08, August – 2022
Title:
20.POST COVID DEPRESSION: A REVIEW OF LITERATURE
Authors :
Mashal Jamil, Mashal Zaman, Anam Amin*, Haroon Khan**, Haleema Sadia***, Jazza Jamil1**
Abstract :
The most common symptoms of coronavirus disease are fever, cough, shortness of breath, muscle pain, headache, diarrhea, rhinorrhea, loss of smell and taste. In addition, there are more and more reports of mental health problems in people who have survived SARS-CoV-2 infection. The most frequently described mental disorders are major depressive disorder (MDD), post-traumatic stress disorder (PTSD), anxiety disorders, obsessive-compulsive disorders (OCD) and insomnia. MDD is hypothesized to be an active inflammatory process with elevated pro- and anti-inflammatory cytokines and oxidative stress. Depression is a leading cause of disability globally. Accordingly, depressive symptoms and clinically-significant depression in post-COVID-19 syndrome may have severe implications as it relates to quality-of-life outcomes. There is also a lack of comprehensive studies directly linking MDD and its biomarkers to COVID-19. Furthermore, it remains to be determined whether the high frequency of depression among individuals with post-COVID-19 syndrome is a long-term consequence of the viral infection or a result of the social and/or economic outcomes of the pandemic.
Keywords: Corona virus; Depression; Post Covid; Major Depressive Episode.
Cite This Article:
Please cite this article in press Mashal Jamil et al, Post Covid Depression: A Review Of Literature., Indo Am. J. P. Sci, 2022; 09(8).
,
Number of Downloads : 10
References:
1. WHO Coronavirus Disease (COVID-19) Dashboard. Dashboard with Vaccination Data. Available online: https://covid19.who.int/
2. Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuinness L., Clarke E.L., Wade R.G. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE. 2020;15:e0234765.
3. Vaira L.A., Salzano G., Deiana G., De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020;130:1787. doi: 10.1002/lary.28692
4. Lai C.-C., Shih T.-P., Ko W.-C., Tang H.-J., Hsueh P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55:105924.
5. Steardo L., Steardo L., Verkhratsky A. Psychiatric face of COVID-19. Transl. Psychiatry. 2020;10:261. doi: 10.1038/s41398-020-00949-5.
6. Kong X., Zheng K., Tang M., Kong F., Zhou J., Diao L., Wu S., Jiao P., Su T., Dong Y. Prevalence and Factors Associated with Depression and Anxiety of Hospitalized Patients with COVID-19. medRxiv. 2020
7. Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594–600.
8. De Lorenzo R., Conte C., Lanzani C., Benedetti F., Roveri L., Mazza M.G., Brioni E., Giacalone G., Canti V., Sofia V., et al. Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS ONE. 2020;15:e0239570.
9. Bo H.-X., Li W., Yang Y., Wang Y., Zhang Q., Cheung T., Wu X., Xiang Y.-T. Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychol. Med. 2020;51:1052–1053.
10. James S.L., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–1858.
11. Depression. [(accessed on 31 August 2021)]. Available online: https://www.who.int/health-topics/depression#tab=tab_1
12. Nabbe P., Le Reste J., Guillou-Landreat M., Perez M.M., Argyriadou S., Clavería A., Fernandez-San-Martin M.I., Czachowski S., Lingner H., Lygidakis C., et al. Which DSM validated tools for diagnosing depression are usable in primary care research? A systematic literature review. Eur. Psychiatry. 2017;39:99–105.
13. Ng C.W.M., How C.H., Ng Y.P. Major depression in primary care: Making the diagnosis. Singap. Med. J. 2016;57:591–597. doi: 10.11622/smedj.2016174.
14. Gadad B., Jha M., Czysz A., Furman J.L., Mayes T.L., Emslie M.P., Trivedi M.H. Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks. J. Affect. Disord. 2017;233:3–14. doi: 10.1016/j.jad.2017.07.001.
15. Smith K.M., Renshaw P.F., Bilello J. The diagnosis of depression: Current and emerging methods. Compr. Psychiatry. 2012;54:1–6.
16. Gałecki P., Talarowska M. Inflammatory theory of depression. Psychiatr. Polska. 2018;52:437–447.
17. Lorkiewicz P, Waszkiewicz N. Biomarkers of Post-COVID Depression. J Clin Med. 2021 Sep 14;10(18):4142. doi: 10.3390/jcm10184142. PMID: 34575258; PMCID: PMC8470902.
18. Troyer E.A., Kohn J.N., Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020;87:34–39.
19. Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77:1018–1027.
20. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259
21. Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021 Dec;144:129-137.